R. Paul Johnson, MD, Director
(founded 1930)

Dedicated to discovering causes, prevention, treatments, and cures of disease, Emory National Primate Research Center (ENPC) is improving human and animal health and lives worldwide. One of seven NPRCs funded by the NIH, ENPC conducts studies that make breakthrough discoveries possible. Research involves 1,000 nonhuman primates at its main center on the Emory campus and another 2,500 at its field station in Lawrenceville, Georgia. The center also has 7,500 rodents in its research vivaria.

ENPC has 352 staff members and 64 faculty scientists. Supported by $73.1 million in research funding (all sources) in FY 2019, the Center ranked first in NIH funding among NPRCs. ENPC grounds its research in scientific integrity, expert knowledge, respect for colleagues, an open exchange of ideas, and compassionate, quality animal care. Researchers are making landmark discoveries in microbiology and immunology; neurologic diseases; neuropharmacology; behavioral, cognitive, and developmental neuroscience; and psychiatric disorders. The center's research advances vaccine development for infectious and noninfectious diseases, paves the way for earlier diagnosis of and new treatments for illnesses such as Alzheimer’s and Parkinson’s, defines the neurobiology and genetics of social behavior to support new therapies for autism spectrum and other disorders as well as drug addiction, and teaches us how interactions between genetics and environment shape who we are.

The center follows regulations and guidelines established by the NIH, the US Department of Agriculture, and more. Since 1984, it has been fully accredited by the AAALAC International, regarded as the gold seal of approval for laboratory animal care.